Sara Borok
- Clinical Biochemistry top 2%
- Epidemiology
- Oncology
- Molecular Medicine top 5%
- Pharmacology top 10%
- Co-authors
- Leonard LeiboviciMical PaulAbigail FraserLiat VidalMichal CohenAnat Gafter‐GviliUwe FrankSteen Andreassen
- Topics
- Bacterial Identification and Susceptibility Testing (5 papers)Spondyloarthritis Studies and Treatments (5 papers)Autoimmune and Inflammatory Disorders Research (5 papers)
- Journals
- Cochrane Database of Systematic ReviewsThe American Journal of MedicineJournal of Antimicrobial Chemotherapy
- Partner nations
- IsraelUnited KingdomUnited States
In The Last Decade
Sara Borok
15 papers receiving 548 citations
Peers
Comparison fields: 5 of 67
- Clinical Biochemistry 206
- Epidemiology 157
- Oncology 156
- Molecular Medicine 110
- Pharmacology 105
Countries citing papers authored by Sara Borok
This map shows the geographic impact of Sara Borok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Borok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Borok more than expected).
Fields of papers citing papers by Sara Borok
This network shows the impact of papers produced by Sara Borok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Borok. The network helps show where Sara Borok may publish in the future.
Co-authorship network of co-authors of Sara Borok
This figure shows the co-authorship network connecting the top 25 collaborators of Sara Borok. A scholar is included among the top collaborators of Sara Borok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Borok. Sara Borok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 6 | |
| 5 | 19 | |
| 6 | 34 | |
| 7 | Clinical Images: Marked Inflammation in a Patient with Cervical Vertebral SAPHO Complicated by Vertebral Body Collapse and Severe Kyphosis. | 2 |
| 8 | 85 | |
| 9 | 6 | |
| 10 | 24 | |
| 11 | 108 | |
| 12 | 153 | |
| 13 | 73 | |
| 14 | 34 | |
| 15 | 2 |
About Sara Borok
Sara Borok is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology and Hematology, having authored 15 papers that have together received 560 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (5 papers), Spondyloarthritis Studies and Treatments (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (104 citations), Clinical Biochemistry (206 citations) and Molecular Medicine (110 citations). Sara Borok has collaborated with scholars based in Israel, United Kingdom and United States. Frequent co-authors include Leonard Leibovici, Mical Paul, Abigail Fraser, Liat Vidal, Michal Cohen, Anat Gafter‐Gvili, Uwe Frank, Steen Andreassen, Anders D. Nielsen and N. Almanasreh. Their work appears in journals such as Cochrane Database of Systematic Reviews, The American Journal of Medicine and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.